SCHEMBL4033508

SCHEMBL4033508

OC(c1ccc2c3c(ccc2c1)OCCC3)c1cn(C(c2ccccc2)(c2ccccc2)c2ccccc2)cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4027157 0.94 USP9X (0.30)
SCHEMBL7532936 0.91 FLT3 (0.33)
SCHEMBL4029004 0.78 NPC1 (0.37)
SCHEMBL4027506 0.77 ENPP2 (0.31)
SCHEMBL9518468 0.73 ENPP2 (0.33)
SCHEMBL21636129 0.72 SIRT2 (0.35)
SCHEMBL5682208 0.72 AKR1C3 (0.40)
SCHEMBL4023986 0.72 VNN1 (0.36)
SCHEMBL14249054 0.72 SIRT2 (0.34)
SCHEMBL1414837 0.72 SIRT2 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1222174-B1 IMIDAZOL-4-YLMETHANOLS USED AS INHIBITORS OF STEROID C17-20 LYASE TAKEDA PHARMACEUTICAL (JP) 2009-05-27 EP disclosed
US-6649643-B1 Antitumor, anticarcinogenic, and antimetastasis agents; benign prostatic hyperplasia, alopecia, endometriosis, uterine myoma, hirsutism, virilism, precocious puberty, mastopathy, and polycystic overay syndrome treatment TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-11-18 US disclosed